Effect of Nutraceutical Factors on Hepatic Intermediary Metabolism in Wistar Rats with Induced Tendinopathy
- PMID: 38203800
- PMCID: PMC10779845
- DOI: 10.3390/ijms25010629
Effect of Nutraceutical Factors on Hepatic Intermediary Metabolism in Wistar Rats with Induced Tendinopathy
Abstract
Tendinopathy (TP) is a complex clinical syndrome characterized by local inflammation, pain in the affected area, and loss of performance, preceded by tendon injury. The disease develops in three phases: Inflammatory phase, proliferative phase, and remodeling phase. There are currently no proven treatments for early reversal of this type of injury. However, the metabolic pathways of the transition metabolism, which are necessary for the proper functioning of the organism, are known. These metabolic pathways can be modified by a number of external factors, such as nutritional supplements. In this study, the modulatory effect of four dietary supplements, maslinic acid (MA), hydroxytyrosol (HT), glycine, and aspartate (AA), on hepatic intermediary metabolism was observed in Wistar rats with induced tendinopathy at different stages of the disease. Induced tendinopathy in rats produces alterations in the liver intermediary metabolism. Nutraceutical treatments modify the intermediary metabolism in the different phases of tendinopathy, so AA treatment produced a decrease in carbohydrate metabolism. In lipid metabolism, MA and AA caused a decrease in lipogenesis at the tendinopathy and increased fatty acid oxidation. In protein metabolism, MA treatment increased GDH and AST activity; HT decreased ALT activity; and the AA treatment does not cause any alteration. Use of nutritional supplements of diet could help to regulate the intermediary metabolism in the TP.
Keywords: Achilles tendon; aspartate; glycine; hydroxytyrosol; maslinic acid; nutritional factors; rehabilitation; tendinitis.
Conflict of interest statement
The authors of this work declare that this research has been carried out in the absence of any commercial or financial relationship and, therefore, does not present any conflict of interest now or in the future. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Similar articles
-
The Efficacy of Intratissue Percutaneous Electrolysis (EPI®) and Nutritional Factors for the Treatment of Induced Tendinopathy in Wistar Rats: Hepatic Intermediary Metabolism Effects.Int J Mol Sci. 2024 Jul 3;25(13):7315. doi: 10.3390/ijms25137315. Int J Mol Sci. 2024. PMID: 39000426 Free PMC article.
-
Alteration in the liver metabolome of rats with metabolic syndrome after treatment with Hydroxytyrosol. A Mass Spectrometry And Nuclear Magnetic Resonance - based metabolomics study.Talanta. 2018 Feb 1;178:246-257. doi: 10.1016/j.talanta.2017.09.029. Epub 2017 Sep 11. Talanta. 2018. PMID: 29136819
-
Hydroxytyrosol ameliorates metabolic, cardiovascular and liver changes in a rat model of diet-induced metabolic syndrome: Pharmacological and metabolism-based investigation.Pharmacol Res. 2017 Mar;117:32-45. doi: 10.1016/j.phrs.2016.12.002. Epub 2016 Dec 8. Pharmacol Res. 2017. PMID: 27940206
-
Nutritional Supplements in the Clinical Management of Tendinopathy: A Scoping Review.J Sport Rehabil. 2023 May 5;32(5):493-504. doi: 10.1123/jsr.2022-0244. Print 2023 Jul 1. J Sport Rehabil. 2023. PMID: 37146985
-
Achilles Tendinopathy Pathogenesis and Management: A Narrative Review.Int J Environ Res Public Health. 2023 Aug 30;20(17):6681. doi: 10.3390/ijerph20176681. Int J Environ Res Public Health. 2023. PMID: 37681821 Free PMC article. Review.
Cited by
-
The Efficacy of Intratissue Percutaneous Electrolysis (EPI®) and Nutritional Factors for the Treatment of Induced Tendinopathy in Wistar Rats: Hepatic Intermediary Metabolism Effects.Int J Mol Sci. 2024 Jul 3;25(13):7315. doi: 10.3390/ijms25137315. Int J Mol Sci. 2024. PMID: 39000426 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical